| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +37.8% |
| Cost of Revenue | $461.3M | +43.1% |
| Gross Profit | $728.6M | +34.7% |
| R&D Expense | $233.8M | +20.5% |
| SG&A Expense | $401.6M | -22.0% |
| Operating Income | $93.3M | +155.5% |
| Pre-tax Income | $196.5M | +239.0% |
| Income Tax | $49.4M | +160.7% |
| Net Income | $147.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $353.7M | -0.7% |
| Short-term Investments | $581.8M | +3909.4% |
| Inventory | $202.5M | +86.3% |
| Current Assets | $1.81B | +62.7% |
| Total Assets | $2.85B | +68.9% |
| Current Liabilities | $602.6M | +44.0% |
| Total Liabilities | $1.58B | +147.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $235.4M | +89.1% |
| Capital Expenditures | $55.8M | +11.9% |
| Investing Cash Flow | -$831.0M | -429.0% |
| Financing Cash Flow | $598.1M | +443.4% |
| Free Cash Flow | $179.6M | +140.7% |
| +345.2% |
| EPS (Basic) | $2.07 | +327.5% |
| EPS (Diluted) | $2.03 | +323.1% |
| Stockholders' Equity |
| $1.27B |
| +21.1% |